Piel最新文献

英文中文

Abordaje quirúrgico en semiluna: una técnica novedosa para la resección de un schwannoma en la punta nasal 半月牙手术：一种切除鼻尖毛囊瘤的新技术

Q4 Medicine

Piel

Pub Date : 2026-01-01 DOI: 10.1016/j.piel.2025.03.018

M. Fernanda Echeverría , Valentina Burckhardt-Bravo , Miquela Martínez , Andrés Figueroa

引用次数: 0

Principales opciones terapéuticas distintas a los corticoesteroides para el tratamiento de los queloides 非糖皮质激素治疗瘢痕疙瘩的主要治疗方案

Q4 Medicine

Piel

Pub Date : 2026-01-01 DOI: 10.1016/j.piel.2025.03.005

Estefania Tobar Salcedo, Sofía Montenegro Montufar, Paula Andrea Candelo Viafara, Laura Lucía Alarcón Montealegre

引用次数: 0

Dermatitis liquenoide anular de la infancia: una entidad poco conocida con rasgos clínico-patológicos distintivos 儿童期环状地衣皮炎：具有明显临床病理特征的鲜为人知的实体

Q4 Medicine

Piel

Pub Date : 2026-01-01 DOI: 10.1016/j.piel.2025.05.013

María Fernanda Gallo Miranda , Victoria Lucía Dávila Osorio , Cristina Vélez Arroyave

引用次数: 0

Fluorescencia axilar. Diagnóstico y comentario axilar荧光。诊断与评论

Q4 Medicine

Piel

Pub Date : 2026-01-01 DOI: 10.1016/j.piel.2025.10.002

José Javier Mateos Rico, Marta Gutiérrez Pascual

引用次数: 0

Alopecia cicatricial, celulitis disecante 松弛，松弛

Q4 Medicine

Piel

Pub Date : 2026-01-01 DOI: 10.1016/j.piel.2025.03.020

Pamela Pérez-García, Freddy Caques- Segovia, Rodrigo León Restrepo-Molina, Sara Londoño-Urrea

引用次数: 0

Impacto del programa piloto de teledermatología en el Hospital General Docente Calderón del Ecuador 在厄瓜多尔卡尔德龙多森特总医院实施远程医疗试点方案的影响

Q4 Medicine

Piel

Pub Date : 2026-01-01 DOI: 10.1016/j.piel.2025.03.015

Cindy Tipán Abril , Jessica Sandoval Rivera , Estefany Proaño Patiño , Lorena Vaca Peñafiel , Luis Tipaz Chingal

Introduction

The demand for dermatologic consultations has increased worldwide, especially in rural areas where patients must travel long distances to access a dermatologist. Teledermatology (TD) emerges as a tool to expand care to these areas. In Ecuador, Telemedicine began in 2008, and in 2022 Hospital General Docente Calderón (HGDC) implemented a pilot plan in Dermatology, although its impact had not been evaluated.

Materials and methods

Retrospective observational descriptive study to evaluate the results of the TD program at HGDC since its implementation (October 2022–July 2024). Sociodemographic and clinical variables collected from all patients seen from the anonymized database of the MD-SOS system were analyzed. This is a minimal risk study approved by the ethics committee of the HGDC.

Results

40 patients were attended using the synchronous videoconference model (Zoom platform), 25 women (62%) with an average age of 43 years. The most prevalent pathologies were benign skin tumors (25%), such as seborrheic keratosis (12.5%), followed by pityriasis versicolor (8%), psoriasis vulgaris (8%) and lichen simplex chronicus (8%). Thirty percent were seen exclusively by TD, while 70% required face-to-face evaluation, with a waiting time ranging from one week to 3 months. Diagnostic concordance was 88.9%.

Conclusions

TD made it possible to keep patients at the first level of care, reduced waiting time for specialized care, and saved time for patients by avoiding their double transfer to the hospital. Although TD has not been fully utilized, it is recommended that its implementation be expanded to benefit more people.

世界范围内对皮肤科会诊的需求有所增加，特别是在农村地区，患者必须长途跋涉才能找到皮肤科医生。远程皮肤病学（TD）作为一种将护理扩展到这些领域的工具而出现。在厄瓜多尔，远程医疗于2008年开始实施，2022年，总医医院Calderón （HGDC）在皮肤科实施了一项试点计划，尽管其影响尚未得到评估。材料和方法回顾性观察性描述性研究，评估自HGDC实施TD计划以来（2022年10月至2024年7月）的结果。从MD-SOS系统的匿名数据库中收集的所有患者的社会人口学和临床变量进行分析。这是一项由HGDC伦理委员会批准的最小风险研究。结果采用同步视频会议模式（Zoom平台）的患者40例，女性25例（62%），平均年龄43 岁。最常见的病理是良性皮肤肿瘤（25%），如脂溢性角化病（12.5%），其次是花斑糠疹（8%）、寻常型牛皮癣（8%）和慢性单纯苔藓（8%）。30%的患者由TD独家治疗，而70%的患者需要面对面评估，等待时间从一周到3个 个月不等。诊断符合率为88.9%。结论性病可使患者保持在一级护理，减少专科护理的候诊时间，避免患者多次转院，节省患者时间。虽然TD尚未得到充分利用，但建议扩大其实施范围，使更多的人受益。

{"title":"Impacto del programa piloto de teledermatología en el Hospital General Docente Calderón del Ecuador","authors":"Cindy Tipán Abril , Jessica Sandoval Rivera , Estefany Proaño Patiño , Lorena Vaca Peñafiel , Luis Tipaz Chingal","doi":"10.1016/j.piel.2025.03.015","DOIUrl":"10.1016/j.piel.2025.03.015","url":null,"abstract":"<div><h3>Introduction</h3><div>The demand for dermatologic consultations has increased worldwide, especially in rural areas where patients must travel long distances to access a dermatologist. Teledermatology (TD) emerges as a tool to expand care to these areas. In Ecuador, Telemedicine began in 2008, and in 2022 Hospital General Docente Calderón (HGDC) implemented a pilot plan in Dermatology, although its impact had not been evaluated.</div></div><div><h3>Materials and methods</h3><div>Retrospective observational descriptive study to evaluate the results of the TD program at HGDC since its implementation (October 2022–July 2024). Sociodemographic and clinical variables collected from all patients seen from the anonymized database of the MD-SOS system were analyzed. This is a minimal risk study approved by the ethics committee of the HGDC.</div></div><div><h3>Results</h3><div>40 patients were attended using the synchronous videoconference model (Zoom platform), 25 women (62%) with an average age of 43 years. The most prevalent pathologies were benign skin tumors (25%), such as seborrheic keratosis (12.5%), followed by pityriasis versicolor (8%), psoriasis vulgaris (8%) and lichen simplex chronicus (8%). Thirty percent were seen exclusively by TD, while 70% required face-to-face evaluation, with a waiting time ranging from one week to 3 months. Diagnostic concordance was 88.9%.</div></div><div><h3>Conclusions</h3><div>TD made it possible to keep patients at the first level of care, reduced waiting time for specialized care, and saved time for patients by avoiding their double transfer to the hospital. Although TD has not been fully utilized, it is recommended that its implementation be expanded to benefit more people.</div></div>","PeriodicalId":20182,"journal":{"name":"Piel","volume":"41 1","pages":"Pages 3-8"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146015528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Alopecia areata en la edad pediátrica: impacto en la calidad de vida de los pacientes y sus familiares 儿童期斑秃：对患者及其家庭成员生活质量的影响

Q4 Medicine

Piel

Pub Date : 2026-01-01 DOI: 10.1016/j.piel.2025.03.014

María Dolores Pegalajar-García , Israel Pérez-López , Ricardo Ruiz-Villaverde , César Hueso- Montoro , Leticia Alonso-Castro

Introduction

Alopecia areata (AA) is the third most common dermatosis in children. There are few studies on the impact on the quality of life (QOL) of patients and their families.

Material and methods

A cross-sectional study was conducted to describe the clinical and demographic characteristics of pediatric patients with AA and the impact on the QOL of these patients and their parents in a tertiary hospital from January to June 2023. Data were collected using a questionnaire including clinical, demographic and quality of life variables using the Children Dermatology Life Quality Index (CDLQI) and Family Dermatology Life Quality Index (FDLQI) questionnaires. Data were analyzed using SPSS (version 25.0, IBM Corp.®).

Results

Ten patients were included, with male predominance (70%), mean age 7.6 years (SD 3.6) and atopic dermatitis as main comorbidity (50%). The impact on QOL was mild in patients (CDLQI 3.8 [SD 3.5]), and moderate in their parents (FDLQI 7.2 [SD 3.8]), significantly associated with the use of alternative non-pharmacological treatments (p = 0.043 and p = 0.034), unrelated to clinical or associated comorbidities.

Conclusions

It is essential to actively investigate the impact on QOL in patients with AA or their relatives given its lack of association with clinical severity factors. Improvement of the current QOL questionnaires in pediatric patients with this disease would be necessary to understand its true impact.

斑秃（AA）是儿童第三大常见皮肤病。对患者及其家属生活质量影响的研究较少。材料与方法对某三级医院2023年1 - 6月儿童AA患者的临床、人口学特征及其对患儿及其家长生活质量的影响进行横断面研究。采用儿童皮肤病生活质量指数（CDLQI）和家庭皮肤病生活质量指数（FDLQI）问卷调查收集数据，包括临床、人口统计学和生活质量变量。数据分析使用SPSS （version 25.0, IBM Corp.®）。结果纳入患者10例，男性居多（70%），平均年龄7.6 岁（SD 3.6），主要合并症为特应性皮炎（50%）。患者对生活质量的影响为轻度（CDLQI 3.8 [SD 3.5]），父母对生活质量的影响为中度（FDLQI 7.2 [SD 3.8]），与替代非药物治疗的使用显著相关（p = 0.043和p = 0.034），与临床或相关合并症无关。结论AA患者及其亲属生活质量与临床严重程度因素缺乏相关性，有必要积极调查其对患者生活质量的影响。为了了解其真正的影响，有必要改进目前儿科患者的生活质量问卷。

{"title":"Alopecia areata en la edad pediátrica: impacto en la calidad de vida de los pacientes y sus familiares","authors":"María Dolores Pegalajar-García , Israel Pérez-López , Ricardo Ruiz-Villaverde , César Hueso- Montoro , Leticia Alonso-Castro","doi":"10.1016/j.piel.2025.03.014","DOIUrl":"10.1016/j.piel.2025.03.014","url":null,"abstract":"<div><h3>Introduction</h3><div>Alopecia areata (AA) is the third most common dermatosis in children. There are few studies on the impact on the quality of life (QOL) of patients and their families.</div></div><div><h3>Material and methods</h3><div>A cross-sectional study was conducted to describe the clinical and demographic characteristics of pediatric patients with AA and the impact on the QOL of these patients and their parents in a tertiary hospital from January to June 2023. Data were collected using a questionnaire including clinical, demographic and quality of life variables using the Children Dermatology Life Quality Index (CDLQI) and Family Dermatology Life Quality Index (FDLQI) questionnaires. Data were analyzed using SPSS (version 25.0, IBM Corp.®).</div></div><div><h3>Results</h3><div>Ten patients were included, with male predominance (70%), mean age 7.6 years (SD 3.6) and atopic dermatitis as main comorbidity (50%). The impact on QOL was mild in patients (CDLQI 3.8 [SD 3.5]), and moderate in their parents (FDLQI 7.2 [SD 3.8]), significantly associated with the use of alternative non-pharmacological treatments (<em>p</em> = 0.043 and <em>p</em> = 0.034), unrelated to clinical or associated comorbidities.</div></div><div><h3>Conclusions</h3><div>It is essential to actively investigate the impact on QOL in patients with AA or their relatives given its lack of association with clinical severity factors. Improvement of the current QOL questionnaires in pediatric patients with this disease would be necessary to understand its true impact.</div></div>","PeriodicalId":20182,"journal":{"name":"Piel","volume":"41 1","pages":"Pages 9-13"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146015529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Nevus de quiste triquilemal 囊肿

Q4 Medicine

Piel

Pub Date : 2026-01-01 DOI: 10.1016/j.piel.2025.04.005

Cristina Marcos Rodríguez, Marta Gutiérrez Pascual, Araceli Sánchez Gilo, Francisco Javier Vicente Martín

引用次数: 0

Tumor genital doloroso en una mujer de mediana edad. Diagnóstico y comentario 中年妇女生殖器疼痛肿瘤。诊断与评论

Q4 Medicine

Piel

Pub Date : 2026-01-01 DOI: 10.1016/j.piel.2025.10.001

Valeria Alfaro-Fierro , Valentina Garrido-Ortiz , Juan Pablo Morales-Etcheberry

引用次数: 0

Alopecia cicatricial de rápida evolución en una mujer de mediana edad 中年妇女瘢痕性脱发的快速发展

Q4 Medicine

Piel

Pub Date : 2026-01-01 DOI: 10.1016/j.piel.2025.04.004

Flavia Giubergia Canepa , Andrea M. Bernales Salinas , Daniel Hernández Cáceres , Fernando Millard San Martín

引用次数: 0

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Piel

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀